These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10759898)

  • 1. Pregnancy outcome following prescription for sumatriptan.
    Olesen C; Steffensen FH; Sorensen HT; Nielsen GL; Olsen J
    Headache; 2000 Jan; 40(1):20-4. PubMed ID: 10759898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery outcome in women who used drugs for migraine during pregnancy with special reference to sumatriptan.
    Källén B; Lygner PE
    Headache; 2001 Apr; 41(4):351-6. PubMed ID: 11318881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of sumatriptan in pregnancy: a review of the data so far.
    Loder E
    CNS Drugs; 2003; 17(1):1-7. PubMed ID: 12467489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final results from the 16-year sumatriptan, naratriptan, and treximet pregnancy registry.
    Ephross SA; Sinclair SM
    Headache; 2014; 54(7):1158-72. PubMed ID: 24805878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and overuse of sumatriptan. Pharmacoepidemiological studies based on prescription register and interview data.
    Gaist D
    Cephalalgia; 1999 Oct; 19(8):735-61. PubMed ID: 10570730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revised estimates for probability of successful outcome of pregnancy after sumatriptan exposure.
    Fox AW
    Headache; 2004 Mar; 44(3):293-4. PubMed ID: 15012675
    [No Abstract]   [Full Text] [Related]  

  • 7. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The safety of sumatriptan and naratriptan in pregnancy: what have we learned?
    Cunnington M; Ephross S; Churchill P
    Headache; 2009; 49(10):1414-22. PubMed ID: 19804390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery outcome after maternal use of drugs for migraine: a register study in Sweden.
    Källén B; Nilsson E; Otterblad Olausson P
    Drug Saf; 2011 Aug; 34(8):691-703. PubMed ID: 21751829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of migraine headaches with sumatriptan in pregnancy.
    Hilaire ML; Cross LB; Eichner SF
    Ann Pharmacother; 2004 Oct; 38(10):1726-30. PubMed ID: 15316107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse pregnancy outcome in women exposed to acyclovir during pregnancy: a population-based observational study.
    Ratanajamit C; Vinther Skriver M; Jepsen P; Chongsuvivatwong V; Olsen J; Sørensen HT
    Scand J Infect Dis; 2003; 35(4):255-9. PubMed ID: 12839155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Birth outcome in women exposed to 5-aminosalicylic acid during pregnancy: a Danish cohort study.
    Nørgård B; Fonager K; Pedersen L; Jacobsen BA; Sørensen HT
    Gut; 2003 Feb; 52(2):243-7. PubMed ID: 12524407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
    Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
    Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan: what do we know about fetal risks?
    Olesen C; Olsen J
    Headache; 2001 Feb; 41(2):206-7. PubMed ID: 11251709
    [No Abstract]   [Full Text] [Related]  

  • 15. Birth outcomes in women exposed to anticonvulsant drugs.
    Fonager K; Larsen H; Pedersen L; Sørensen HT
    Acta Neurol Scand; 2000 May; 101(5):289-94. PubMed ID: 10987315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based assessment of pregnancy outcome after sumatriptan exposure.
    Fox AW; Chambers CD; Anderson PO; Diamond ML; Spierings EL
    Headache; 2002 Jan; 42(1):8-15. PubMed ID: 12005279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hazards of medication refills by telephone.
    Solomon S
    Headache; 2002 Sep; 42(8):835. PubMed ID: 12390654
    [No Abstract]   [Full Text] [Related]  

  • 18. Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero.
    Dencker BB; Larsen H; Jensen ES; Schønheyder HC; Nielsen GL; Sørensen HT
    Clin Microbiol Infect; 2002 Apr; 8(4):196-201. PubMed ID: 12047410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sumatriptan in Denmark in 1994-5: an epidemiological analysis of nationwide prescription data.
    Gaist D; Andersen M; Aarup AL; Hallas J; Gram LF
    Br J Clin Pharmacol; 1997 Apr; 43(4):429-33. PubMed ID: 9146856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.
    Yusuf A; Chia V; Xue F; Mikol DD; Bollinger L; Cangialose C
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1309-1315. PubMed ID: 30240072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.